Nutriband (NASDAQ:NTRBW) Stock Price & Analysis

$0.974

USD

+0.584(149.74%)

At close: Sep 11, 20:17 EDT

Open

$0.85

Prev. Close

$0.39

High

$1.00

Low

$0.85

Company Profile

Nutriband Inc. is a pharmaceutical company dedicated to advancing a diverse pipeline of transdermal drug products. Foremost among its developmental initiatives is an abuse-deterrent fentanyl transdermal system. This innovative patch aims to provide both healthcare providers and patients with an extended-release fentanyl solution for the effective management of chronic pain. Beyond its core transdermal portfolio, Nutriband Inc. also holds a licensing agreement with Rambam Med-Tech Ltd. for the development of RAMBAM Closed System Transfer Devices. Established in 2016, the company maintains its corporate headquarters in Orlando, Florida.

CEOGareth Sheridan

SectorHealthcare

IndustryBiotechnology

Employees

Recently from Cashu

3

IPO DateOct 1, 2021

ExchangeNASDAQ

Exchange NameNASDAQ Capital Market

CurrencyUSD

Headquarters & Contact

Address121 South Orange Avenue

City / State / ZIPOrlando, FL, 32801

CountryUnited States

Phone407 377 6695

Websitehttps://nutriband.com